Compare Stocks → The AI Defense Stock Set to Soar (From Behind the Markets) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:ADILWNASDAQ:BCTXWNASDAQ:BFRIWNASDAQ:LBPSW Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeADILWAdial Pharmaceuticals, Inc. WT EXP 073123$0.00-57.1%$0.00$0.00▼$0.20N/AN/A7,487 shs5,100 shsBCTXWBriaCell Therapeutics$1.28+6.7%$1.58$0.71▼$3.30N/AN/A12,800 shs20,574 shsBFRIWBiofrontera$0.04-36.3%$0.03$0.01▼$0.37N/AN/A8,454 shs2,446 shsLBPSW4D pharma$0.00$0.04▼$1.29N/AN/A20,931 shsN/AThese 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceADILWAdial Pharmaceuticals, Inc. WT EXP 0731230.00%0.00%0.00%0.00%-97.57%BCTXWBriaCell Therapeutics+6.67%+10.34%-6.57%-43.11%-56.61%BFRIWBiofrontera-32.50%-31.58%-14.39%+240.78%-78.08%LBPSW4D pharma0.00%0.00%+3,057.14%0.00%+4,811.11%The AI Defense Stock Set to Soar (Ad)To protect our interests, The Pentagon has partnered with this small AI defense contractor - creating some of the most powerful AI defenses ever made.Here's how you can invest >>>MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationADILWAdial Pharmaceuticals, Inc. WT EXP 073123N/AN/AN/AN/AN/AN/AN/AN/ABCTXWBriaCell TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/ABFRIWBiofronteraN/AN/AN/AN/AN/AN/AN/AN/ALBPSW4D pharmaN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceADILWAdial Pharmaceuticals, Inc. WT EXP 073123N/AN/AN/AN/ABCTXWBriaCell TherapeuticsN/AN/AN/AN/ABFRIWBiofronteraN/AN/AN/AN/ALBPSW4D pharmaN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookADILWAdial Pharmaceuticals, Inc. WT EXP 073123N/AN/AN/AN/AN/AN/ABCTXWBriaCell TherapeuticsN/AN/AN/AN/AN/AN/ABFRIWBiofrontera$34.07MN/AN/AN/AN/AN/ALBPSW4D pharma$522KN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateADILWAdial Pharmaceuticals, Inc. WT EXP 073123N/AN/A0.00∞N/AN/AN/AN/AN/ABCTXWBriaCell TherapeuticsN/AN/A0.00∞N/AN/AN/AN/AN/ABFRIWBiofronteraN/AN/A0.00∞N/AN/AN/AN/AN/ALBPSW4D pharmaN/AN/A0.00N/AN/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthADILWAdial Pharmaceuticals, Inc. WT EXP 073123N/AN/AN/AN/AN/ABCTXWBriaCell TherapeuticsN/AN/AN/AN/AN/ABFRIWBiofronteraN/AN/AN/AN/AN/ALBPSW4D pharmaN/AN/AN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipADILWAdial Pharmaceuticals, Inc. WT EXP 073123N/ABCTXWBriaCell TherapeuticsN/ABFRIWBiofronteraN/ALBPSW4D pharmaN/AInsider OwnershipCompanyInsider OwnershipADILWAdial Pharmaceuticals, Inc. WT EXP 073123N/ABCTXWBriaCell TherapeuticsN/ABFRIWBiofronteraN/ALBPSW4D pharmaN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableADILWAdial Pharmaceuticals, Inc. WT EXP 07312320N/AN/ANot OptionableBCTXWBriaCell Therapeutics16N/AN/ANot OptionableBFRIWBiofrontera81N/AN/ANot OptionableLBPSW4D pharmaN/AN/AN/ANot OptionableADILW, LBPSW, BFRIW, and BCTXW HeadlinesNo headlines for this company have been tracked by MarketBeat.comMedia Sentiment Over TimeCompany DescriptionsAdial Pharmaceuticals, Inc. WT EXP 073123NASDAQ:ADILWadial pharmaceuticals is dedicated to personalized treatment for drug abuse and addiction. while our pipeline includes drug candidates for the treatment of opiate and amphetamine use, our two lead drug candidates are for the treatment of alcohol abuse. adial leverages its extensive knowledge of pharmacology and pharmacogenomics to change the paradigm of drug abuse treatment.BriaCell TherapeuticsNASDAQ:BCTXWBriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers. The company has a collaboration with Incyte Corporation to evaluate combination of the Bria-IMT. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.BiofronteraNASDAQ:BFRIWBiofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, a prescription drug for use in combination with the BF-RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It also provides Xepi, a topical non-fluorinated quinolone that inhibits bacterial growth for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.4D pharmaNASDAQ:LBPSW Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.